Wipasa Jiraprapa, Elliott Salenna, Xu Huji, Good Michael F
The Cooperative Research Centre for Vaccine Technology, The Queensland Institute of Medical Research, Australia.
Immunol Cell Biol. 2002 Oct;80(5):401-14. doi: 10.1046/j.1440-1711.2002.01107.x.
The development of a malaria vaccine seems to be a definite possibility despite the fact that even individuals with a life time of endemic exposure do not develop sterile immunity. An effective malaria vaccine would be invaluable in preventing malaria-associated deaths in endemic areas, especially amongst children less than 5 years of age and pregnant women. This review discusses our current understanding of immunity against the asexual blood stage of malaria - the stage that is responsible for the symptoms of the disease - and approaches to the design of an asexual blood stage vaccine.
尽管即使是长期暴露于疟疾流行地区的个体也不会产生无菌免疫,但疟疾疫苗的研发似乎具有明确的可能性。一种有效的疟疾疫苗对于预防流行地区与疟疾相关的死亡,尤其是5岁以下儿童和孕妇中的死亡,将具有不可估量的价值。这篇综述讨论了我们目前对针对疟疾无性血液阶段(即导致疾病症状的阶段)免疫的理解,以及无性血液阶段疫苗的设计方法。